Lorenzo Maso, Sarah A. Mosure, Sergio A. Rodriguez-Aponte, Angelina Pizzo, Diamond N. Mensah, Matthew Southard, Samantha Sze, Tanvir Ahmed, Brian Vash, Takamitsu Hattori, Epsa Rajak, Akiko Koide, Benjamin G. Neel, Shohei Koide, Weifeng Liu, Sean T. Toenjes, Paul Da Silva Jardine, Rajesh Chopra, Christoph Rader, Lauren E. Stopfer. "Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy." Nature Communications (2025). https://doi.org/10.1038/s41467-025-66132-w